NovaBridge Biosciences (NBP) Non-cash Items (2019 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Non-cash Items data on file, last reported at $15.4 million in Q4 2025.

• Quarterly Non-cash Items changed N/A year-over-year to $15.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.4 million (changed N/A YoY) and the FY2025 annual result came in at $15.4 million, changed N/A from the prior year.
• Non-cash Items climbed to $15.4 million in Q4 2025 per NBP's latest filing, from $217936.1 in the prior quarter.
• Across five years, Non-cash Items topped out at $15.4 million in Q4 2025 and bottomed at $49766.7 in Q4 2022.
• The 3-year median for Non-cash Items is $217936.1 (2023), against an average of $5.2 million.
• Peak annual rise in Non-cash Items reached 337.92% in 2023, while the deepest fall reached 337.92% in 2023.
• Tracing NBP's Non-cash Items over 3 years: stood at $49766.7 in 2022, then surged by 337.92% to $217936.1 in 2023, then surged by 6964.0% to $15.4 million in 2025.
• Per Business Quant, the three latest NBP Non-cash Items figures stand at $15.4 million (Q4 2025), $217936.1 (Q4 2023), and $49766.7 (Q4 2022).

Peer Comparison